Compare ARDX & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARDX | GOOS |
|---|---|---|
| Founded | 2007 | 1957 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 975.9M | 931.6M |
| IPO Year | 2014 | 2016 |
| Metric | ARDX | GOOS |
|---|---|---|
| Price | $3.42 | $7.46 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $15.14 | $12.60 |
| AVG Volume (30 Days) | ★ 3.9M | 870.3K |
| Earning Date | 04-30-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,607,000.00 | N/A |
| Revenue This Year | $37.75 | $12.21 |
| Revenue Next Year | $34.24 | $5.16 |
| P/E Ratio | ★ N/A | $75.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $7.36 |
| 52 Week High | $8.40 | $14.69 |
| Indicator | ARDX | GOOS |
|---|---|---|
| Relative Strength Index (RSI) | 24.11 | 33.20 |
| Support Level | N/A | N/A |
| Resistance Level | $3.92 | $8.32 |
| Average True Range (ATR) | 0.12 | 0.25 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 14.53 | 8.33 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.